Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
27 participants
OBSERVATIONAL
2020-08-06
2020-12-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Parent Nurse Controlled Analgesic in Pediatric Patients With Developmental Delay
NCT00743730
A Study of Two Injection Techniques to Reduce Pain in Infants Undergoing Immunization
NCT01601197
Olfactive Stimulation Interventions With Mothers' Milk on Preterm Pain Response
NCT04062513
Measuring Analgesic Interventions
NCT03794362
Effectiveness of Parent-Led Interventions in Reducing Infant Hypersensitivity to Pain
NCT01503060
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clinicians
Clinicians who care for pediatric patients \>50% of their time, who treat pediatric patients who are in acute pain and between 0 and 3 years of age. May include physicians, clinical pharmacists, nurse practitioners, physician assistants, and/or nurses.
This cohort will complete a qualitative interview about pain and distress in infants and young children.
Qualitative Interview
There is no intervention as part of this study. Clinicians will participate in a qualitative interview.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Qualitative Interview
There is no intervention as part of this study. Clinicians will participate in a qualitative interview.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Cares for pediatric patients \>50% of their time
3. Treats or works with pediatric patients who are between 0 and \<3 years of age AND being treated for acute pain
4. Holds one of the following titles/positions
1. Physician
2. Clinical pharmacist (PharmD)
3. Nurse practitioner
4. Physician assistant
5. Nurse (with a BSN/RN or higher)
5. Is over the age of 18 years
6. Can speak and understand English
7. Is capable of giving informed verbal consent
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Food and Drug Administration (FDA)
FED
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bryce Reeve, PhD
Role: PRINCIPAL_INVESTIGATOR
Duke University
Kanecia Zimmerman, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke University
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00105109
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.